Last Price$19.1(7.5%)
Market Cap$14.6B
$0.0
N/A
($221.3M)
-86.6% YoY
($405.1M)
Net Debt to FCF - 2.9x
($142.1M)
N/A
SMMT Income Statement
SMMT Income Statement Overview
Annual
Quarterly
LTM
Jan'16
Jan'17
Jan'18
Jan'19
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Cost of revenue
$15.0M 632.0% YoY
Pre-tax income
$221.3M (64.1%) YoY
0.0% margin
SMMT Income statement key metrics
Annual
Quarterly
LTM
SMMT Balance Sheet
SMMT Balance Sheet Overview
Annual
Quarterly
LTM
Jan'16
Jan'17
Jan'18
Jan'19
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$435.6M
Current assets ($423.8M, 97.3% of total)
$412.3M (94.7%)
$0.0 (0.0%)
Other current assets
$11.4M (2.6%)
Non-current assets ($11.8M, 2.7% of total)
$0.0 (0.0%)
$7,398.0K (1.7%)
$0.0 (0.0%)
Other non-current assets
$4,412.0K (1.0%)
Financial position
($405.1M)
Cash & Short-term
Investments
Total Debt
SMMT Balance Sheet Metrics
Annual
Quarterly
LTM
SMMT Cash Flow Statement
SMMT Cash Flow Statement Overview
Annual
Quarterly
LTM
Jan'16
Jan'17
Jan'18
Jan'19
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$33.8M Net Change in Cash
SMMT Cash Flow Statement key metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
($142.1M) +85.1% YoY
Capital Expenditure (CAPEX)
($139.0K) +8.5% YoY
Free Cash Flow (FCF)
($142.2M) +84.8% YoY
SMMT Financials
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Jan'06 | Jan'07 | Jan'08 | Jan'09 | Jan'10 | Jan'11 | Jan'12 | Jan'13 | Jan'14 | Jan'15 | Jan'16 | Jan'17 | Jan'18 | Jan'19 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 1.7 338.9% | 3.8 119.8% | 12.1 219.9% | 0.5 (96.0%) | 0.5 (1.1%) | 1.9 290.6% | 4.4 138.3% | 4.6 2.5% | 3.6 (21.8%) | 3.7 4.3% | 0.0 (100.0%) | 3.9 0.0% | 46.8 1,114.8% | 74.9 59.9% | 0.8 (98.9%) | 0.9 6.6% | 1.8 110.3% | 0.7 (61.1%) | 0.0 (100.0%) | 0.0 0.0% |
| Cost of Goods Sold (COGS) | 0.8 | 1.1 | 5.0 | 0.0 | 0.0 | 0.0 | 1.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.2 | 0.0 | 0.0 | 2.5 | 2.1 | 15.0 |
% margin | 1.0 56.1% | 2.7 70.6% | 7.0 58.3% | 0.5 97.8% | 0.5 100.0% | 1.9 100.0% | 2.8 63.7% | 4.6 100.0% | 3.6 100.0% | 3.7 100.0% | 0.0 0.0% | 3.9 100.0% | 46.7 99.7% | 74.8 100.0% | 0.6 75.4% | 0.9 100.0% | 1.8 100.0% | (1.8) (257.0%) | (2.1) 0.0% | (15.0) 0.0% |
| Operating Expenses | 6.8 | 18.6 | 53.9 | 27.9 | 15.0 | 8.6 | 11.9 | 13.5 | 20.9 | 31.6 | 44.8 | 45.4 | 70.4 | 63.3 | 53.6 | 53.2 | 88.0 | 64.3 | 87.7 | 211.3 |
| Research & Development Expenses (R&D) | 3.3 | 10.8 | 30.7 | 13.3 | 5.8 | 5.7 | 7.7 | 9.1 | 17.0 | 25.6 | 36.4 | 31.7 | 53.4 | 68.2 | 41.7 | 53.3 | 85.4 | 52.0 | 59.5 | 150.8 |
| Selling, General & Administrative Expenses (SG&A) | 3.2 | 3.5 | 14.6 | 9.1 | 6.6 | 4.1 | 3.7 | 4.4 | 5.1 | 11.1 | 11.3 | 13.8 | 22.1 | 21.5 | 11.9 | 19.2 | 23.6 | 26.7 | 28.2 | 60.5 |
% margin | (5.8) (338.9%) | (16.0) (423.8%) | (46.9) (388.4%) | (34.7) (7,198.9%) | (14.5) (3,047.6%) | (14.5) (777.1%) | (7.6) (170.1%) | (11.5) (252.3%) | (17.4) (487.9%) | (31.3) (844.4%) | (43.7) 0.0% | (41.6) (1,078.7%) | (23.7) (50.7%) | 16.4 21.9% | (54.6) (6,766.4%) | (53.2) (6,185.2%) | (86.2) (4,764.3%) | (72.1) (10,235.6%) | (89.7) 0.0% | 0.3 0.0% |
| Interest Income | 1.9 | 3.2 | 3.1 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.7 | 4.9 | 0.0 | 0.0 | 0.2 | 1.5 | 10.4 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.0 | 1.4 | 2.1 | 0.7 | 0.0 | 0.3 | 0.3 | 4.4 | 16.5 | (8.7) |
| Pre-tax Income | (3.9) | (12.8) | (43.9) | (34.2) | (14.7) | (14.4) | (7.5) | (11.5) | (17.3) | (31.2) | (43.7) | (43.0) | (20.1) | 8.8 | (36.3) | (52.9) | (88.6) | (78.8) | (615.9) | (221.3) |
% effective tax rate | (0.5) 12.8% | (1.8) 13.9% | (3.6) 8.3% | (4.6) 13.3% | (0.9) 6.4% | (3.0) 20.7% | (0.8) 10.1% | (0.9) 7.5% | (1.6) 9.1% | (3.2) 10.2% | (6.6) 15.2% | (7.3) 16.9% | (6.9) 34.5% | (4.3) (49.6%) | (5.8) 15.9% | (0.2) 0.4% | (2.5) 2.8% | (4.4) 5.6% | (0.9) 0.2% | 0.0 0.0% |
% margin | (3.4) (199.7%) | (11.0) (292.1%) | (40.3) (334.1%) | (58.4) (12,109.8%) | (13.7) (2,867.2%) | (11.4) (614.7%) | (6.8) (152.6%) | (10.6) (232.9%) | (15.8) (443.1%) | (28.0) (754.9%) | (37.0) 0.0% | (35.7) (927.6%) | (13.1) (28.1%) | 13.1 17.5% | (30.5) (3,779.1%) | (52.7) (6,127.6%) | (86.1) (4,762.1%) | (74.4) (10,561.1%) | (614.9) 0.0% | (221.3) 0.0% |
| EPS | (0.11) | (0.30) | (0.84) | (1.09) | (0.21) | (0.07) | (0.04) | (0.67) | (3.26) | (0.70) | (0.62) | (0.58) | (0.21) | 0.15 | (0.19) | (0.76) | (0.93) | (0.38) | (0.99) | (0.31) |
| Diluted EPS | (0.11) | (0.30) | (0.84) | (1.09) | (0.21) | (0.07) | (0.04) | (0.67) | (3.26) | (0.70) | (0.62) | (0.58) | (0.20) | 0.15 | (0.19) | (0.76) | (0.93) | (0.38) | (0.99) | (0.31) |
% margin | (5.4) (313.6%) | (11.4) (302.4%) | (37.2) (308.4%) | (29.0) (6,010.3%) | (8.5) (1,790.5%) | (13.3) (716.0%) | (7.1) (159.0%) | (8.7) (191.3%) | (17.3) (486.0%) | (20.0) (537.9%) | (30.9) 0.0% | (41.5) (1,075.8%) | (41.9) (89.5%) | 15.5 20.7% | (21.4) (2,657.4%) | (37.1) (4,317.9%) | (62.7) (3,468.0%) | (52.6) (7,472.8%) | 1.0 0.0% | 0.3 0.0% |
FAQ
What is the Summit Therapeutics Inc. (SMMT) revenue?
The Summit Therapeutics Inc. (SMMT) revenue is $0.0, reflecting a year-over-year (YoY) growth of N/A.
What is the Summit Therapeutics Inc. (SMMT) Net Income?
The Summit Therapeutics Inc. (SMMT) Net Income is ($221.3M), showcasing a YoY growth of -64.0% YoY.
What is Summit Therapeutics Inc. (SMMT) net debt?
What is the Summit Therapeutics Inc. (SMMT) Free Cash Flow (FCF)?
The Summit Therapeutics Inc. (SMMT) Free Cash Flow (FCF) stands at ($142.2M), accounting for a N/A margin.